Abiopharma

Founded in 2007, Cavitation Technologies, Inc. (CTi) (OTCQB: CVAT), is a leading ESG company, that designs and manufactures innovative flow-through nano-technology systems for fluid processing applications worldwide. The technology is implemented in multiple applications, such as water treatment and remediation, agriculture, pharmaceuticals, edible oil refining, renewable fuels, and beverages. Our core products are Nano Reactor® systems, with scalable capacities ranging from 10 to 500 gallons per minute (GPM), and our latest advancement, Cavitation Non-Thermal Plasma technology, which currently operates at 14 GPM and has a scalability of up to 100 GPM. These systems effectively eliminate bacteria and viruses, reduce TDS levels, lower turbidity, and offer the potential removal of PFAS in multiple water remediation applications. CTi holds over 40 patents issued domestically and internationally.

Additional info from OTC:
Founded in 2007, Cavitation Technologies, Inc. (CTi) (OTCQB: CVAT), is a leading ESG company, that designs and manufactures innovative flow-through nano-technology systems for fluid processing applications worldwide. The technology is implemented in multiple applications, such as water treatment and remediation, agriculture, pharmaceuticals, edible oil refining, renewable fuels, and beverages. Our core products are Nano Reactor® systems, with scalable capacities ranging from 10 to 500 gallons per minute (GPM), and our latest advancement, Cavitation Non-Thermal Plasma technology, which currently operates at 14 GPM and has a scalability of up to 100 GPM. These systems effectively eliminate bacteria and viruses, reduce TDS levels, lower turbidity, and offer the potential removal of PFAS in multiple water remediation applications. CTi holds over 40 patents issued domestically and internationally.